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In further work on the model after the publication, a conversion error in the formula for mortality status post-myocardial
infarction (for the time period beyond the ﬁrst month) was detected that led to an increased cardiovascular mortality.
The corrected formula reads: ProbToProb (tDieMI [sbp; yr]; cl * if (psa ¼1; if (age < 60; 1; if (age  70; dRRdie-
MI70s;dRRdieMI60s)); tRRdieMIage [age])).
After incorporating this correction into the model, the primary outcomes changed as follows. Relative morbidity risks did not
change except for heart failure (0.78/0.94 for 10 years/lifetime instead of 0.79/0.92 previously). Renal denervation-related life
year gains are slightly reduced compared to the published results (1.28 instead of 1.30 incremental life years and 1.07 instead
of 1.10 incremental quality-adjusted life years [QALYs]). However, the incremental cost-effectiveness ratio (ICER) becomes
marginally more favorable and changes from $3,071/QALY to $1,017/QALY (an intervention with an ICER of $50,000 to
$100,000 per QALY is typically considered to be cost-effective). The corresponding 95% credible interval for the ICER,
derived from probabilistic sensitivity analysis, changes from (cost-saving; $31,460/QALY) to (cost-saving; $35,103/QALY).
This effect might stem from the longer survival status post myocardial infarction, which leads to a cost increase for both the
renal denervation and the standard-of-care strategies, but reduces the cost difference between the two. All conclusions of the
study remain unchanged.
The authors apologize for this error.
http://dx.doi.org/10.1016/j.jacc.2013.09.018Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J. Subtle post-procedural cognitive
dysfunction after atrial ﬁbrillation ablation. J Am Coll Cardiol 2013;62:531–9.
An afﬁliation and middle initial were omitted from one of the authors of the above paper.
The author’s name and afﬁliation should have appeared as follows:
Jonathan M. Kalman, MBBS, PhD, Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia, and
the University of Melbourne, Melbourne, Australia.
The authors apologize for the error.
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